Drug intelligence / Profile preview

LetiKerato

Development stage: Unknown
Lead developer: Leti Pharma
Modality: Small Molecules
Administration: Topical

Overview

LetiKerato is a topical veterinary skincare product developed by Leti Pharma (Animal Health) as part of the LETI+Derma line for dogs and cats. It is specifically formulated to manage keratoseborrheic disorders, dry skin, and flaky skin conditions. The product line, which includes both a shampoo and a lotion, utilizes polyhydroxy acids (PHAs) to provide gentle keratolytic and moisturizing effects. These acids help normalize skin cell turnover and improve hydration without the irritation often associated with other hydroxy acids. LetiKerato is frequently used as an adjunct treatment for skin lesions associated with canine leishmaniosis and hereditary ichthyosis in specific breeds.

Brand names: LetiKeratoLetiKerato ShampooLetiKerato Lotion
Other names: LETI+Derma LetiKerato

Beyond the preview

Go deeper on LetiKerato.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LetiKerato.

Explore the full profile